FDA Research Goals
| 1 | 2 | 3 | 4 |

Goal #1 To ensure the safety and effectiveness of HIV-related therapeutic agents.
Objective

Expedite access and approval of safe and effective drugs and biologics.

Action Steps

Encourage quality applications and data submissions to review division to ensure timely and efficient pre- and postmarket review.

Descriptions

Conduct meetings with sponsors to discuss drug development plans, expanded access programs, and accelerated approval options. Facilitate scientific review of drugs and biologics by FDA advisory committees.

Resources
FY95
FY96
FY96
$ 25.2 million
$ 25.2 million
$ 25.2 million
Populations
Served

All persons who may benefit from approved therapeutic agents.

Constituency
Involvement

The FDA depends on scientific advisory committees to provide independent expert advice to the agency in its evaluation of regulated products. These committees are composed of representatives from academia, research, government, industry and patient advocates.


Goal #2 To ensure the safety and effectiveness of HIV-related preventive and therapeutic vaccines.
Objective

Expedite regulatory review of promising products for preventive and therapeutic vaccines.

Action Steps

Expand partnership between FDA and its counterparts from outside organizations involved in vaccine development.

Descriptions

Encourage early consultation with sponsoring companies, develop guidance documents, exchange information, and work with other agencies and international organizations. Facilitate scientific review by FDA advisory committees.

Resources
FY95
FY96
FY96
$ 11.9 million
$ 11.9 million
$ 11.9 million
Populations
Served

All persons who may benefit from approved preventive and therapeutic vaccines.

Constituency
Involvement

The FDA depends on scientific advisory committees to provide independent expert advice to the agency in its evaluation of regulated products. These committees are composed of representatives from academia, research, government, industry, and patient advocates.


Goal #3 To ensure the effectiveness of test methodologies for HIV detection and measurement.
Objective

Expedite improved test methodologies (such as diagnostic reagents and test kits) for HIV detection, confirmation, and viral load measurement.

Action Steps

Ensure timely and efficient pre- and post-market review.

Descriptions

Encourage early consultation with sponsor and develop guidance documents. Facilitate scientific review of drugs and biologics by FDA advisory committees.

Resources
FY95
FY96
FY96
$ 8.7 million
$ 8.7 million
$ 8.7 million
Populations
Served

All persons who may benefit from approved test methodologies for HIV detection and measurement.

Constituency
Involvement

The FDA depends on scientific advisory committees to provide independent expert advice to the agency in its evaluation of regulated products. These committees are composed of representatives from academia, research, government, industry, and patient advocates.


Goal #4

To ensure the safety and effectiveness of HIV-related medical devices.

Objective

Expedited access and approval of safe and effective medical devices.

Action Steps

Encourage quality application and data submissions to ensure timely and efficient pre- and post-market review.

Descriptions

Conduct meetings with sponsors on study design; produce guidance documents. Facilitate scientific review of drugs and biologics by FDA advisory committees.

Resources
FY95
FY96
FY96
$ 9.5 million
$ 9.5 million
$ 9.5 million
Populations
Served

All persons who may benefit from approved HIV-related medical devices.

Constituency
Involvement

The FDA depends on scientific advisory committees to provide independent expert advice to the agency in its evaluation of regulated products. These committees are composed of representatives from academia, research, government, industry, and patient advocates.

 

Back
Top
Continue
[Back]
[Top]
[Continue]

divider
Go to White House Home Page
Go to ONAP Home Page
Go to White House Help Page
White House Home
ONAP Home Page
White House Help